on October 31, 2012 |
Permalink
Topics: Cardiovascular, Service Lines, Outcomes, Quality, Performance Improvement, Technology Assessment, Methodologies
Megan Tooley, Cardiovascular Roundtable
The latest results of the PARTNER Cohort B trial, recently presented at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Miami, demonstrate that the mortality benefits of transcatheter aortic valve replacement (TAVR) in inoperable patients are maintained out to at least three years.
Furthermore, the data provide insight into the impact of comorbidities at the time of implant on outcomes, further emphasizing the importance of careful patient selection for TAVR.
Continue reading:
TAVR outcomes remain strong at three years
on September 14, 2012 |
Permalink
Topics: Cardiac Cath, Cardiovascular, Service Lines, Cardiac Surgery, Business Development, Strategy, Market Trends, Planning, Regionalization and Networks, Outcomes, Quality, Performance Improvement, Finance
Megan Tooley, Cardiovascular Roundtable
The Roundtable recently received a number of member requests regarding the viability of percutaneous coronary intervention (PCI) programs without on-site cardiac surgery. In addition to the latest literature comparing clinical outcomes between programs with and without surgical backup, there are number of other important factors CV leaders must take into account before pursuing this strategy.
Members of the Roundtable may access a summary below of the most recent clinical findings on PCI without surgical backup, as well as other programmatic implications to consider before starting a PCI program.
Continue reading:
Should you pursue a PCI program without surgical backup?
on August 9, 2012 |
Permalink
Topics: Cardiovascular, Service Lines, Patient Portals, Information Technology, Telemedicine, Remote monitoring, Readmissions, Quality, Performance Improvement, Outcomes, Medication Administration, Medication Reconciliation
Eric Bushlow, Cardiovascular Roundtable
Medication management remains challenging for providers as patients continue to be readmitted for non-compliance with medication. With readmission penalties looming and the gradual shift to value-based models of care, programs must rethink how they can help modify patient behavior outside the hospital setting.
New technologies offer some promise in resolving adherence issues, leveraging reminders and behavioral modification to boost compliance. However many of these solutions have seen limited provider adoption aiming to address the growing readmissions problem.
Continue reading:
Three technologies to improve medication adherence
